术前优化慢性阻塞性肺疾病患者或可减少腹股沟下血管腔内血运重建的并发症并改善结局
基于ACS-NSQIP数据库2012至2022年数据,纳入24223例腹股沟下血管腔内血运重建患者,其中2472例(10.21%)合并COPD,经1:1倾向评分匹配后比较30天结局。COPD患者死亡、主要不良心血管事件、肺部并发症及30天再入院风险均高于非COPD患者,其余30天结局两组相当。作者认为术前识别并优化COPD可能有助于预防并发症。
要点
- 腹股沟下血管腔内血运重建患者中10.21%合并COPD,经倾向评分匹配后COPD组30天死亡风险更高(3.24% vs 2.18%)。
- COPD组主要不良心血管事件(3.48% vs 2.47%)、肺部并发症(3.24% vs 2.02%)及30天再入院(15.41% vs 13.23%)均高于非COPD组。
- 作者建议患者可接受微型肺量计检查筛查COPD,若识别出COPD可在术前开始强化吸入治疗和药物治疗。
核心结论
- COPD独立增加腹股沟下血管腔内血运重建后30天死亡及心肺并发症风险。
- 作者认为在考虑侵入性治疗前识别并优化COPD患者对预防并发症可能很重要。
- 作者建议患者可接受微型肺量计检查筛查COPD,若识别出COPD可在术前开始强化吸入治疗和药物治疗。
研究设计与样本
- 回顾性队列研究,数据来自ACS-NSQIP数据库2012至2022年。
- 纳入接受腹股沟下血管腔内血运重建的COPD与非COPD患者,排除年龄小于18岁及急诊病例。
- 共24223例患者,其中2472例(10.21%)合并COPD,采用1:1倾向评分匹配 demographics、基线特征、症状学和麻醉方式。
- 比较两组30天术后结局。
主要发现
- COPD组30天死亡率3.24% vs 非COPD组2.18%(p=0.03)。
- COPD组主要不良心血管事件(MACE)发生率3.48% vs 非COPD组2.47%(p=0.04)。
- COPD组肺部并发症发生率3.24% vs 非COPD组2.02%(p=0.01)。
- COPD组30天再入院率15.41% vs 非COPD组13.23%(p=0.03)。
- 其余30天结局两组相当。
临床怎么用
- 作者认为在考虑侵入性治疗前识别并优化COPD患者对预防腹股沟下血管腔内血运重建并发症可能很重要。
- 作者建议患者可接受微型肺量计检查筛查COPD。
- 作者建议若识别出COPD,患者可在术前开始强化吸入治疗和药物治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peripheral artery disease (PAD) and chronic obstructive pulmonary disease (COPD) are both systemic inflammatory diseases that may share similar pathophysiological pathways. Given their potential overlap, the impact of COPD on perioperative outcomes following infrainguinal endovascular revascularization warrants further examination. Therefore, this study aimed to analyze the 30-day postoperative outcomes for COPD patients after infrainguinal endovascular revascularization. METHODS: Chronic obstructive pulmonary disease and non-COPD patients who underwent infrainguinal endovascular revascularization were identified in the ACS-NSQIP database from 2012 to 2022. Exclusion criteria included aged less than 18 years and emergency cases. A 1:1 propensity-score matching was used to match demographics, baseline characteristics, symptomatology, and anesthesia. Thirty-day postoperative outcomes were compared. RESULTS: Of 24 223 patients who underwent infrainguinal endovascular revascularization, 2472 (10.21%) had COPD. All COPD patients were 1:1 propensity-score-matched to the non-COPD patients. Chronic obstructive pulmonary disease patients had higher risks of mortality (3.24% vs 2.18%, p=0.03), major adverse cardiovascular events (MACE) (3.48% vs 2.47%, p=0.04), pulmonary complications (3.24% vs 2.02%, p=0.01), and 30-day readmission (15.41% vs 13.23%, p=0.03). All other 30-day outcomes were comparable between the groups. CONCLUSION: Chronic obstructive pulmonary disease independently increases the risk of 30-day mortality and cardiopulmonary complications after infrainguinal endovascular revascularization. Identification and optimization of COPD patients before considering invasive treatment can be important for preventing complications. Patients may undergo mini-spirometry to screen for COPD. If identified, COPD patients may begin intensive inhalation therapy and medical treatment prior to the surgery.Clinical ImpactBoth PAD and COPD are systemic inflammatory diseases that may share similar pathophysiological pathways. This study analyzed the 30-day postoperative outcomes for COPD patients after infrainguinal endovascular revascularization. It was found that COPD independently increases the risk of mortality, cardiopulmonary complications, and 30-day readmissions. Identification and optimization of COPD patients before considering invasive treatment can be important for preventing complications in infrainguinal endovascular revascularization. Patients may undergo mini-spirometry to screen for COPD. If identified, COPD patients may begin intensive inhalation therapy and medical treatment prior to the surgery.
引用
- Li R, Silverman R, Sidawy A, et al. Optimizing Patients With Chronic Obstructive Pulmonary Disease Preoperatively May Reduce Complications and Improve Outcomes in Infrainguinal Endovascular Revascularization. J Endovasc Ther. 2025. PMID: 39981935. doi:10.1177/15266028251320506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。